Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE)

CUSIP: 03836J102

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
6,583,303
Total 13F shares
1,587,074
Share change
-44,778
Total reported value
$520,280
Put/Call ratio
2.5%
Price per share
$0.33
Number of holders
23
Value change
-$37,678
Number of buys
12
Number of sells
10

Quarterly Holders Quick Answers

What is CUSIP 03836J102?
CUSIP 03836J102 identifies APRE - Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE) as of Q4 2022

As of 31 Dec 2022, Aprea Therapeutics, Inc. - Common Stock, $0.001 par value per share (APRE) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,587,074 shares. The largest 10 holders included VANGUARD GROUP INC, MORGAN STANLEY, BlackRock Inc., RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, Tower Research Capital LLC (TRC), GROUP ONE TRADING, L.P., and STATE STREET CORP. This page lists 23 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.